It also plays a key role in understanding how intelligent AI is, preventing the misallocation of resources, and guiding ...
Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® (sparsentan) to reduce proteinuria in adult and pediatric patients aged 8 years and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results